• News
    • Latest news
    • News search
    • Health
    • Finance
    • Food
    • Career news
    • Content series
    • Try Devex Pro
  • Jobs
    • Job search
    • Post a job
    • Employer search
    • CV Writing
    • Upcoming career events
    • Try Career Account
  • Funding
    • Funding search
    • Funding news
  • Talent
    • Candidate search
    • Devex Talent Solutions
  • Events
    • Upcoming and past events
    • Partner on an event
  • Post a job
  • About
      • About us
      • Membership
      • Newsletters
      • Advertising partnerships
      • Devex Talent Solutions
      • Contact us
Join DevexSign in
Join DevexSign in

News

  • Latest news
  • News search
  • Health
  • Finance
  • Food
  • Career news
  • Content series
  • Try Devex Pro

Jobs

  • Job search
  • Post a job
  • Employer search
  • CV Writing
  • Upcoming career events
  • Try Career Account

Funding

  • Funding search
  • Funding news

Talent

  • Candidate search
  • Devex Talent Solutions

Events

  • Upcoming and past events
  • Partner on an event
Post a job

About

  • About us
  • Membership
  • Newsletters
  • Advertising partnerships
  • Devex Talent Solutions
  • Contact us
  • My Devex
  • Update my profile % complete
  • Account & privacy settings
  • My saved jobs
  • Manage newsletters
  • Support
  • Sign out
Latest newsNews searchHealthFinanceFoodCareer newsContent seriesTry Devex Pro
    • News
    • Global Health

    Two types of drugs kill nearly 500,000 in sub-Saharan Africa each year

    Substandard or fake antimalarial and antibiotics are killing an estimated 436,000 each year.

    By Sara Jerving // 02 February 2023

    Related Stories

    Ghana's Delese Mimi Darko appointed to lead African Medicines Agency
    Ghana's Delese Mimi Darko appointed to lead African Medicines Agency
    Can Africa’s drug regulators be both fast and trusted?
    Can Africa’s drug regulators be both fast and trusted?
    Africa inches toward local production of vaccines and more
    Africa inches toward local production of vaccines and more
    A revolutionary HIV drug won't matter if patients can't afford it
    A revolutionary HIV drug won't matter if patients can't afford it

    Nearly half a million people in sub-Saharan Africa die each year at the hands of two types of substandard or fake drugs, according to a new threat assessment report from the United Nations Office on Drugs and Crime.

    This includes 267,000 deaths a year from antimalarial medicines and another 169,271 deaths from antibiotics to treat severe pneumonia in children.

    The report says that high prevalence of infectious diseases coupled with challenges in access to health care, including affordability, means “demand for medical products and services is not fully met through formal channels” creating an opening for organized criminals involved in trafficking.

    This article is free to read - just register or sign in

    Access news, newsletters, events and more.

    Join usSign in
    • Global Health
    • Trade & Policy
    • Research
    • Private Sector
    • Funding
    Printing articles to share with others is a breach of our terms and conditions and copyright policy. Please use the sharing options on the left side of the article. Devex Pro members may share up to 10 articles per month using the Pro share tool ( ).

    About the author

    • Sara Jerving

      Sara Jervingsarajerving

      Sara Jerving is a Senior Reporter at Devex, where she covers global health. Her work has appeared in The New York Times, the Los Angeles Times, The Wall Street Journal, VICE News, and Bloomberg News among others. Sara holds a master's degree from Columbia University Graduate School of Journalism where she was a Lorana Sullivan fellow. She was a finalist for One World Media's Digital Media Award in 2021; a finalist for the Livingston Award for Young Journalists in 2018; and she was part of a VICE News Tonight on HBO team that received an Emmy nomination in 2018. She received the Philip Greer Memorial Award from Columbia University Graduate School of Journalism in 2014.

    Search for articles

    Related Stories

    Global healthGhana's Delese Mimi Darko appointed to lead African Medicines Agency

    Ghana's Delese Mimi Darko appointed to lead African Medicines Agency

    Global healthCan Africa’s drug regulators be both fast and trusted?

    Can Africa’s drug regulators be both fast and trusted?

    Global HealthAfrica inches toward local production of vaccines and more

    Africa inches toward local production of vaccines and more

    Opinion: Global healthA revolutionary HIV drug won't matter if patients can't afford it

    A revolutionary HIV drug won't matter if patients can't afford it

    Most Read

    • 1
      Africa CDC chief: 60% of foreign health aid was effectively wasted
    • 2
      Forgotten liver health and its importance in the NCD agenda
    • 3
      How to adapt digital development solutions to a +1.5°C world
    • 4
      Revolutionizing lung cancer care and early screening in LMICs
    • 5
      Mott MacDonald shuts international development arm amid UK aid turmoil
    • News
    • Jobs
    • Funding
    • Talent
    • Events

    Devex is the media platform for the global development community.

    A social enterprise, we connect and inform over 1.3 million development, health, humanitarian, and sustainability professionals through news, business intelligence, and funding & career opportunities so you can do more good for more people. We invite you to join us.

    • About us
    • Membership
    • Newsletters
    • Advertising partnerships
    • Devex Talent Solutions
    • Post a job
    • Careers at Devex
    • Contact us
    © Copyright 2000 - 2025 Devex|User Agreement|Privacy Statement